Penda Learning | November 16, 2022
Penda Learning, a Learning 2020 company, announced today that it has finalized an agreement with Scantron for the use of more than 14,500 assessment items in 11 assessment banks that span all science disciplines. These items will be used to expand the assessments currently available with Penda Science — a game-based science curriculum for grades 3–8, physical science, environmental science, and biology. — to include all NGSS performance expectations and state-specific science standards. Unlike traditional assessments, Penda Science interactive assessments challenge students to achieve high scores that earn them points to unlock virtual worlds, customize their avatars, and more. Teachers and administrators can use the line item analysis data to pinpoint learning gaps and personalize instruction within the Penda Science platform for small groups and individuals to help students achieve science mastery.
"This agreement will dramatically accelerate the development of comprehensive assessments within Penda Science. High-quality, validated assessments are critical for teachers to make informed decisions about instruction and intervention in order to support science learning success for all students. We are excited to be able to offer students a more interactive and engaging assessment experience and educators the reliable data they need."
Brad Baird, President/CEO of Learning 2020
The new assessment development is slated to be completed by April 2023. Assessments will be available for diagnostic, formative, and summative purposes. Also new to the Penda assessment suite will be a "quick check" assessment for teachers to use before, during, or after a unit to gauge student learning in order to plan or modify instruction to align with student knowledge.
About Learning 2020
Learning 2020, parent company to Penda Learning, is dedicated to identifying pressing, unfilled needs within the K-12 education market and developing technology solutions that solve these challenges in innovative and cost-effective ways that will positively impact teaching and learning. Formed in early 2019 by Brad Baird and Bill Tudor, experienced education technology entrepreneurs, Learning 2020's current focus is on ensuring all students have access to high-quality STEM instruction whether learning at home or in school.
Connected Nation | September 27, 2022
Connected Nation (CN) today announced the launch of a Digital Literacy and Learning program in collaboration with AT&T. The program, which is part of AT&T's national digital literacy initiative to help narrow the Digital Divide, will offer in-person and virtual digital literacy training workshops in underserved areas across the country where training is needed most for the digital empowerment of residents. CN will partner with local community organizations in each area to host training workshops from September 2022 through March 2023. In addition, CN will lead virtual and in-person workshops for military families at its Digital Works office in Fort Campbell, Kentucky"Digital literacy has long been part of Connected Nation's mission ensuring that every person is able to use technology meaningfully is absolutely essential in today's digital economy, said Heather Gate, Executive Vice President of Digital Inclusion. This program provides us the opportunity to meet people where they are in their digital skills level, confidence with embracing technology, and interest in enhancing their skills as new technology adopters. There is no better way to do this than by collaborating with trusted partners to bring much-needed training to local communities across the country. We are excited to get started. To launch this program, CN staff is reaching out to communities that previously participated in the nonprofit's technology planning process and identified digital literacy as a need. "Offering a tangible skill like digital literacy training to communities that Connected Nation works with allows us to model closing the Digital Divide in a real way," said Pamela Waggoner, Broadband Solutions Manager.
The amount of federal and state funding earmarked for broadband initiatives continues to grow. More communities than ever have access to these funds, and can use them to bring programs like this one to their residents.
"In recent months, there has been a considerable emphasis and focus on the large investments being made by federal and state governments to support the buildout of very high-speed networks across our communities.We also need to prepare these communities with the tools and training necessary to take advantage of these capabilities to help improve their lives. This initiative will be a significant factor in addressing that need."
Dan Manning, CN Broadband Solutions Manager
About Connected Nation
Connected Nation celebrated 20 years of service in 2021. The national nonprofit's mission is to improve lives by providing innovative solutions that expand access to and increase the adoption and use of broadband (high-speed internet) and its related technologies for all people. Everyone belongs in a Connected Nation.
Manchester University | November 03, 2022
GenXys, the global leader in precision prescribing software with embedded pharmacogenetic (PGx) data, is teaming up with Manchester University (MU) for pharmacogenomics education. Together, GenXys and MU will help drive global awareness and education of PGx-informed prescribing decisions in support of expanding PGx adoption and pending legislation in the U.S., including the Right Drug Dose Now Act. MU, located in northern Indiana, is a leading national academic institution with a strong educational and research stream in pharmacogenetics. With on-campus, online, and dual (PharmD/MS in PGx) degree programs, as well as a Graduate Certificate in PGx, MU typically has an annual PGx enrollment of 60 to 70 students. The partnership will enable GenXys' expertise and proprietary algorithms in genomics and clinical knowledge to support the expansion of genetically informed medication review capabilities in MU's educational and research space. MU will now be able to integrate GenXys' award-winning Clinical Decision Support Systems (CDSS), incorporating PGx with other patient data points through embedded translation and interpretation in specific degree programs. This will lead to students further learning appropriate evidence-based precision prescribing options for patients, ultimately leading to better health outcomes and empowering the next generation of clinicians to seamlessly utilize PGx in patient care. As a national leader in pharmacogenetic and clinical education, Manchester University looks to partner with leading-edge technology companies that further the advancement of PGx for better health outcomes, says David Kisor, PharmD, FCP, Professor of Pharmaceutical Sciences and Pharmacogenomics, Director of Pharmacogenomics at MU. "It is recognized that more than 95 percent of the population has at least one PGx variant, and large percentages of patients receiving medications across therapeutic areas do not respond adequately with an initial medication leading to trial-and-error prescribing. Additionally, the consequences and treatments of adverse drug events may cost more than $30 billion annually in the U.S.," Dr. Kisor adds. "By formally measuring the effect of automatic PGx inclusion in CDSS tools in education as well as incorporating GenXys' precision prescribing platform into our advanced courses, we aim to produce the most knowledgeable and equipped individuals who will apply PGx optimally across healthcare settings. Integration of the precision prescribing platform offered by GenXys into the educational content of MU will accelerate the knowledge uptake of PGx in prescribing decisions for the next generation of clinicians and other healthcare professionals.
"By working with a stellar academic university like MU, we are able to demonstrate the advantage of including PGx in clinical care for clinicians across different career levels ,There are so many advantages to equipping students and trainees with leading-edge tools and knowledge—the future is looking bright for precision medicine!"
Bernard Esquivel, MD, PhD, Chief Medical Officer of GenXys.
Auto-analysis of genetic information with other medication interaction points is helping to transform the centuries-old trial-and-error approach to prescribing to one of accuracy. PGx is all about personalized, safe, and appropriate medication options being available at any point of care. When integrated into smart algorithms with other data points, PGx is a critical part of proactive healthcare delivering precision medicine to everyone and leveling up healthcare inequality. MU is at the educational edge of changing day-to-day healthcare, and the partnership with GenXys is a model of commercial and academic integration that supports pending national legislation to provide better population healthcare, improve patient safety, and reduce healthcare costs.
About GenXys Health Care Systems
GenXys, with a presence across North America, provides the world's most comprehensive precision prescribing solutions with embedded pharmacogenetics to solve one of healthcare's biggest challenges: inappropriate ("trial-and-error") prescribing. GenXys' clinical decision support software suite is in use by major insurance providers, health systems, pharmacies and their pharmacogenetic labs across North America. Ongoing global clinical studies are paving the way into geographical markets to enable GenXys to realize its vision of making every prescription better with its software to increase patient safety, improve population health, and reduce healthcare costs. https://www.genxys.com/
About Manchester University
Manchester University, in North Manchester and Fort Wayne, Ind., provides vibrant and transformative student experiences. Manchester University respects the infinite worth of every individual and graduates persons of ability and conviction who draw upon their education and faith to lead principled, productive, and compassionate lives that improve the human condition.